Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma. [electronic resource]
Producer: 20030221Description: 4413-9 p. digitalISSN:- 0732-183X
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carmustine -- administration & dosage
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Germany
- Humans
- L-Lactate Dehydrogenase -- blood
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Prednisolone -- administration & dosage
- Prognosis
- Prospective Studies
- Radiotherapy, Adjuvant
- Risk
- Stem Cell Transplantation
- Survival Analysis
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.